• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMM

IMMUTEP LIMITED

1.85% ! 26.5¢
Market Cap $388.9M  !

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company... Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein that is an antigen-presenting cell (APC) agonist designed to capitalize on LAG-3’s ability to drive the adaptive and innate immune systems against cancer. IMP761 is an immunosuppressive agonist antibody to LAG-3, which has the potential to address the root cause of autoimmune diseases by specifically silencing autoimmune memory T cells. Its third product candidate is LAG525, an antagonist (blocking) antibody targeting the LAG-3 molecule on T cells with potential applications in the treatment of cancer. Its fourth product candidate is IMP731 (GSK 781), a depleting (cytotoxic) antibody that is intended to destroy LAG-3 expressing activated T cells involved in autoimmunity.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IMM 20:35 15 3.9K
20:35 Last post  bioqld Comments Created with Sketch.  15  Views Created with Sketch.  3.9K 
IMM
Under New Management
2
11:07 73 39K
11:07 Last post  PerthisOk9 Comments Created with Sketch.  73  Views Created with Sketch.  39K 
IMM 29/07/25 13 5.1K
29/07/25 Last post  bioqld Comments Created with Sketch.  13  Views Created with Sketch.  5.1K 
IMM 29/07/25 0 386
29/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  386 
IMM 25/07/25 9 4.1K
25/07/25 Last post  theoc Comments Created with Sketch.  9  Views Created with Sketch.  4.1K 
IMM 25/07/25 0 837
25/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  837 
IMM 23/07/25 31 13K
23/07/25 Last post  Bsee Comments Created with Sketch.  31  Views Created with Sketch.  13K 
IMM
Data Accumulation/Trial Maturity/Efficacy
19/07/25 0 517
19/07/25 Last post  ahjay Comments Created with Sketch.  0  Views Created with Sketch.  517 

See All Discussions arrow Created with Sketch.

Timeline

Immutep Quarterly Activities Report and Appendix 4C
30 Jul 08:25
 
TACTI-004 trial in progress poster to be presented at WCLC
29 Jul 08:21
 
Abstracts Accepted for Presentation at ESMO Congress 2025
28 Jul 09:27
 
Ceasing to be a substantial holder
25 Jul 08:16
 
Ceasing to be a substantial holder
23 Jul 17:40
 
Application for quotation of securities - IMM
18 Jul 12:10
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
26.5¢
Change
-0.005(1.85%)
Mkt cap ! $388.9M
Open High Low Value Volume
27.5¢ 27.5¢ 26.5¢ $405.9K 1.498M

Buyers (Bids)

No. Vol. Price($)
7 148657 26.5¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 3626 3
View Market Depth
Last trade - 16.10pm 30/07/2025 (20 minute delay) ?
Last
26.8¢
  Change
-0.005 ( 0.15 %)
Open High Low Volume
27.5¢ 27.5¢ 26.5¢ 741230
Last updated 15.59pm 30/07/2025 ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.